Verification of efficacy and safety of ibandronate or denosumab for postmenopausal osteoporosis after 12-month treatment with romosozumab as sequential therapy: The prospective VICTOR study

Tomonori Kobayakawa, Akiko Miyazaki, Jun Takahashi, Yukio Nakamura